- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Erratum to: Dual HER2 blockade: preclinical and clinical data ; volume:16 ; number:6 ; day:6 ; month:11 ; year:2014 ; pages:1-2 ; date:12.2014
Breast cancer research ; 16, Heft 6 (6.11.2014), 1-2, 12.2014
- Creator
-
Patel, Tejal A.
- Contributor
-
Dave, Bhuvanesh
Rodriguez, Angel A.
Chang, Jenny C.
Perez, Edith A.
Colon-Otero, Gerardo
SpringerLink (Online service)
- DOI
-
10.1186/s13058-014-0468-9
- URN
-
urn:nbn:de:1111-2016032421414
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Patel, Tejal A.
- Dave, Bhuvanesh
- Rodriguez, Angel A.
- Chang, Jenny C.
- Perez, Edith A.
- Colon-Otero, Gerardo
- SpringerLink (Online service)
Other Objects (12)
Dual HER2 blockade: preclinical and clinical data
Die duale HER2-Blockade : Grundlagen und Perspektiven beim Mammakarzinom
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts
Efficacy and safety of dual blockade of HER2 and PD-1 in patients with HER2-positive gastric cancer: a retrospective, multicentre study
Comparison of neoadjuvant single-agent treatment and dual-HER2 blockade for breast-conserving surgery conversion in HER2-positive breast cancer: a meta-analysis
De-escalation of neoadjuvant taxane and carboplatin therapy in HER2-positive breast cancer with dual HER2 blockade: a multicenter real-world experience in China
Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Preclinical research progress in HER2-targeted small-molecule probes for breast cancer
Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism
Dual HER2 blockade: preclinical and clinical data
Die duale HER2-Blockade : Grundlagen und Perspektiven beim Mammakarzinom
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts
Efficacy and safety of dual blockade of HER2 and PD-1 in patients with HER2-positive gastric cancer: a retrospective, multicentre study
Comparison of neoadjuvant single-agent treatment and dual-HER2 blockade for breast-conserving surgery conversion in HER2-positive breast cancer: a meta-analysis
De-escalation of neoadjuvant taxane and carboplatin therapy in HER2-positive breast cancer with dual HER2 blockade: a multicenter real-world experience in China
Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Preclinical research progress in HER2-targeted small-molecule probes for breast cancer
Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism
Dual HER2 blockade: preclinical and clinical data
Die duale HER2-Blockade : Grundlagen und Perspektiven beim Mammakarzinom
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts
Efficacy and safety of dual blockade of HER2 and PD-1 in patients with HER2-positive gastric cancer: a retrospective, multicentre study
Comparison of neoadjuvant single-agent treatment and dual-HER2 blockade for breast-conserving surgery conversion in HER2-positive breast cancer: a meta-analysis
De-escalation of neoadjuvant taxane and carboplatin therapy in HER2-positive breast cancer with dual HER2 blockade: a multicenter real-world experience in China
Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Preclinical research progress in HER2-targeted small-molecule probes for breast cancer